Advaxis: Advaxis GAAP EPS of -$3.83
Advaxis press release (ADXS): Q3 GAAP EPS of -$3.83.As of July 31, 2022, the company had ~$28.2M in cash and cash equivalents.
Read full article »
Advaxis is a New Jersey-based biotechnology company that develops and commercializes immunotherapies for the treatment of cancer.
Read more